Medicare GLP-1 Bridge Program: Weight-Loss Drugs for $50 a Month

For years, there's been a frustrating catch with Medicare: it simply would not cover GLP-1 medications — the popular weight-loss drugs everyone's talking about — when they were prescribed for weight loss alone.

That just changed.

As of July 1, 2026, Medicare launched a brand-new demonstration called the GLP-1 Bridge Program, and it lets certain beneficiaries get certain weight-loss medications for a flat $50 a month.

But — and this is important — it's only for certain people, only certain drugs, and only for a limited time. Let's walk through exactly how it works, who qualifies, and how to get access.

What Is the Medicare GLP-1 Bridge Program?

The Bridge Program is an 18-month demonstration project from the Centers for Medicare & Medicaid Services (CMS). It runs from July 1, 2026 through December 31, 2027.

Why is it called a "bridge"? Because federal law has long prohibited Medicare from covering drugs prescribed purely for weight loss. Medicare actually tried to open this door once before with a proposed effort (sometimes called the "Balance" model), but the drug plan sponsors wouldn't get on board.

This demonstration is a test run. CMS is hoping that by gathering data over these 18 months, they can convince more drug plans to eventually cover these medications permanently.

Key Takeaway: This is a temporary test program with a hard end date of December 31, 2027 — not a permanent Medicare benefit (at least not yet).

The One Rule That Matters Most: It's for Weight Loss ONLY

This is the single most misunderstood part of the program, so pay close attention.

The Bridge Program only covers GLP-1 medications prescribed for weight loss. It does not cover them if you're taking them for:

• Type 2 diabetes
• Cardiovascular (heart) conditions
• Sleep apnea, fatty liver disease, or other medical diagnoses

If you already take a GLP-1 for one of those conditions, you must continue getting it through your normal Part D drug plan — even if it would be cheaper through the Bridge. During the required pre-authorization, if they see you've been prescribed the medication for another health issue, you will be denied.

Key Takeaway: The Bridge Program is strictly for weight loss. If you're already on a GLP-1 for another condition, this program is not for you.

Who Qualifies? It Comes Down to Your BMI

Eligibility is based on your Body Mass Index (BMI), with three tiers. You must also be 18 or older and enrolled in a Medicare Part D plan (either a standalone drug plan or a Medicare Advantage plan with drug coverage).

Tier 1 — BMI of 35 or higher
You qualify right out of the gate. No additional conditions required.

Tier 2 — BMI of 30 to 35 (with a qualifying condition)
You qualify if you also have one of the following:

• Heart failure (preserved ejection fraction)
• Uncontrolled high blood pressure (above 140 or above 90)
• Chronic kidney disease (stage 3 or higher)
• Pre-diabetes
• A prior heart attack or stroke
• Symptomatic artery disease

Tier 3 — BMI of 27 to 30 (with a qualifying condition)
You qualify if you also have one of the following:

• Pre-diabetes
• A prior heart attack
• A prior stroke
• Symptomatic artery disease

If your BMI is below 27, you won't qualify for this program.

How to Calculate Your BMI

You can figure your BMI with a simple formula:

(Your weight in pounds × 703) ÷ (your height in inches, squared)

For example, someone who weighs 185 pounds and is 5'11" (71 inches) would calculate: 185 × 703 = 130,055, divided by 71 × 71 (5,041) = a BMI of about 26.

Or, even easier: just search "BMI calculator" online, plug in your height and weight, and it'll tell you instantly.

Which Medications Are Covered?

Right now, only two manufacturers are participating, with three medications total. This may expand in the future, but as of the program's launch, here's the list:

From Eli Lilly:
• Zepbound — a once-weekly injection pen (the KwikPen formulation)
• Foundayo (orforglipron) — a daily oral tablet

From Novo Nordisk:
• Wegovy — available in injection and tablet forms

Other manufacturers are developing similar medications and may join the program down the road, but for now these are your only covered options.

How the $50 Price Actually Works

Here's where it gets genuinely impressive. The participating manufacturers set a net price of $245 per month for these medications. Under the Bridge Program:

• You pay a flat $50 copay
• Medicare covers the remaining $195

There are no discounts or coupons — the $50 is the price. And because this program stands completely outside the normal Part D system, a few unusual things are true:

• You can fill it at any pharmacy — there's no network
• Your $50 copay does not count toward your Part D deductible or out-of-pocket maximum
• It doesn't matter which drug plan you have — it's a standalone benefit

Behind the scenes, CMS contracted Humana to process the claims and pre-authorizations, but you don't need to be a Humana member. You simply take the prescription to your pharmacy like any other medication.

Key Takeaway: $50 a month, at any pharmacy, regardless of your drug plan. Over the full 18 months, that's about $900 total.

How to Get Started: The Pre-Authorization Process

Getting access is straightforward, but it does require your doctor's involvement:

1. Talk to your provider about whether a GLP-1 for weight loss is right for you.
2. Your provider submits a prior authorization confirming the medication is for weight loss, that you meet the BMI and condition requirements, and that you'll commit to lifestyle changes alongside the medication.
3. Once approved, you're set for the duration of the program. There's no repeated pre-authorization — approval carries you through.
4. Fill your prescription at your pharmacy and pay your $50 copay.

Is It Worth It?

Consider the math. Studies show most people taking a GLP-1 medication lose an average of 15% to 22% of their total body weight over 12 to 18 months.

If you weigh 200 pounds, that could mean losing around 40 pounds. If you weigh 300 pounds, that could be 60 pounds — all for roughly $900 over the life of the program. For a medication that would otherwise cost hundreds of dollars a month, that's a remarkable value.

Just remember: this is not medical advice, and GLP-1 medications aren't right for everyone. Always talk with your doctor about the benefits and risks for your specific situation.

The Bottom Line

The Medicare GLP-1 Bridge Program is a rare and valuable opportunity — but it's temporary, it's specific, and the details matter. If you have a qualifying BMI, aren't already taking these drugs for another condition, and are enrolled in a Part D plan, this could be a genuine game-changer for your health and your wallet.

Navigating Medicare's rules can be confusing, and programs like this come with fine print that's easy to misread. If you have questions about your Medicare coverage, whether you might qualify, or how this fits with your overall plan, I'm here to help — at no cost to you.